Basic Information
Basic information for AL365295.1-202-18aa
Peptide Name AL365295.1-202-18aa
Genome Position chr14:53217976-53218029[+]
Species Human
Peptide Sequence MARVDAKAEEAPRASEGC
Peptide Length 18
Unique No (AL365295.1-203-18aa,AL365295.1-227-18aa,AL365295.1-204-18aa-1,AL365295.1-217-18aa,AL365295.1-208-18aa-1,AL365295.1-210-18aa-2,AL365295.1-212-18aa,AL365295.1-223-18aa,AL365295.1-213-18aa,AL365295.1-216-18aa)
Grand Average of Hydropathicity -0.6722
Relative Molecular Mass 2197.34
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000237356;AL365295.1
Transcript ID/Name ENST00000663444;AL365295.1-202
Transcript Length 2598
Coding Ability 0.2556
DNA Sequence Corresponding to Peptide ATGGCCAGAGTGGACGCCAAGGCTGAGGAGGCGCCGAGAGCCAGTGAGGGCTGC
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :